購買1,510個硬幣後，Semler Scientific（NASDAQ：SMLR）現在擁有3,808 BTC

自2025年初以來購買了1,510枚硬幣後，Semler Scientific（NASDAQ：SMLR）現在擁有3,808 BTC

Semler Scientific (NASDAQ:SMLR) disclosed in its Q1 earnings report that it now owns 3,808 BTC following the purchase of 1,510 coins since the beginning of 2025.

Semler Scientific（NASDAQ：SMLR）在其第一季度收益報告中披露，自2025年初以來購買了1,510個硬幣後，它現在擁有3,808 BTC。

The increasing bitcoin reserve contributed to a 22.2% BTC Yield year to date through May 12 despite a net loss of $64.7 million for the first quarter.

儘管第一季度的淨虧損為6470萬美元，但日益增長的比特幣儲備金迄今為止持續了22.2％的BTC收益率。

“We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings,” said Eric Semler, chairman of Semler Scientific. “And we are excited to launch the Semler Scientific dashboard today on our website to provide the public with regularly updated information on our bitcoin holdings and other key metrics.”

Semler Scientific董事長Eric Semler說：“我們繼續使用運營現金流並從債務和股票融資中獲得收益來增值比特幣阿森納。” “我們很高興今天在我們的網站上啟動Semler Scientific儀表板，以向公眾提供有關比特幣控股和其他關鍵指標的定期更新信息。”

Semler has introduced a public facing Bitcoin Dashboard on its website to provide real time updates on BTC holdings and key performance indicators like BTC Yield, BTC Gain, and BTC $ Gain.

Semler在其網站上介紹了一個面向公共的比特幣儀表板，以提供有關BTC控股和關鍵性能指標（例如BTC收益率，BTC增益和BTC $增益）的實時更新。

In Q1 2025, the company added 894 BTC for $90.7 million, followed by another 616 BTC acquired through May 12 for $59.6 million. The total fair value of the bitcoin holdings is $387.9 million, based on prices as of May 12.

在2025年第1季度，該公司以9070萬美元的價格增加了894 BTC，其次是5月12日至5月12日以5960萬美元收購的616 BTC。根據5月12日的價格，比特幣持有的總公允價值為3.879億美元。

The quarter was marked by substantial non operating charges. These included a $41.8 million unrealized loss from changes in bitcoin valuation and a $29.75 million contingent liability related to an agreement in principle with the U.S. Department of Justice (DOJ).

該季度以大量非運營費用為標誌。其中包括與美國司法部（DOJ）原則上與一項協議有關的比特幣估值變化的4,180萬美元未實現的損失以及2975萬美元的或有責任。

Revenue for Q1 2025 was $8.8 million, down 44% year-over-year. Operating expenses surged to $39.9 million, driven by litigation provisions and audit related costs. As a result, the company reported a pre-tax loss of $74.9 million.

第一季度2025年第1季度的收入為880萬美元，同比下降44％。在訴訟規定和與審計相關費用的驅動下，運營費用飆升至3990萬美元。結果，該公司報告的稅前虧損為7490萬美元。

MD and CEO of Semler Scientific Doug Murphy-Chutorian said the company’s healthcare business is showing early promise from its cardiovascular product line, “We are expecting growth and cash generation from these FDA-cleared products and services, which will add to our bitcoin treasury strategy.”

Semler科學Doug Murphy-Chutorian的醫學博士兼首席執行官表示，該公司的醫療保健業務正在從其心血管產品系列中表現出早期的希望：“我們期望這些FDA清算產品和服務從這些FDA清除產品和服務中產生增長和現金，這將增加我們的比特幣國庫策略。”

Semler also detailed several financing initiatives, including a $100 million convertible notes offering and a new at the market equity program, which has raised over $61 million to date under its latest agreement.

Semler還詳細介紹了幾項融資計劃，其中包括1億美元的可轉換票據產品和Market Equity計劃的新融資計劃，該計劃迄今已根據其最新協議籌集了超過6100萬美元。